ANDA 60290, held by Purepac Pharm. Tetracycline Hydrochloride.
As of Nov 16, 2026, ANDA 60290 (Tetracycline Hydrochloride), held by Purepac Pharm, was not approved, with 0 approved supplements and 0 published complete response letters.
| Tetracycline Hydrochloride250MG · capsule;oral | Tetracycline Hydrochloride | Discontinued |
| Tetracycline Hydrochloride500MG · capsule;oral | Tetracycline Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters